FDA Panel Turns Down Columbia, Watson Preterm Birth Gel
Columbia Laboratories Inc. and Watson Pharmaceuticals Inc. hit a potential setback on Friday when a U.S. Food and Drug Administration advisory committee recommended against approving their vaginal gel product for preterm...To view the full article, register now.
Already a subscriber? Click here to view full article